Positive Results for Mifepristone in Treating Hypercortisolism and Type 2 Diabetes: CATALYST Trial
USA: Mifepristone (Korlym) shows significant HbA1c improvement in hypercortisolism and difficult-to-control diabetes; Corcept announces positive results in the CATALYST Trial. Corcept Therapeutics Incorporated, a commercial-stage company, has announced …